Omada Health, Inc. Depreciation and Amortization
Omada Health, Inc. (OMDA) reported Depreciation and Amortization of $3.09 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Cash Flow › Operating Activities
us-gaap:DepreciationDepletionAndAmortization · last filed 2026-08-07
- Omada Health, Inc. depreciation, depletion and amortization for the quarter ending 2026-06-30 was $1.58M, a 16.94% increase year-over-year.
- Omada Health, Inc. depreciation, depletion and amortization for the quarter ending 2026-03-31 was $1.51M, a 13.13% increase year-over-year.
- Omada Health, Inc. depreciation, depletion and amortization for the quarter ending 2025-12-31 was $1.45M, a 13.22% increase year-over-year.
- Omada Health, Inc. depreciation, depletion and amortization for the quarter ending 2025-09-30 was $1.36M, a 10.58% increase year-over-year.
- Omada Health, Inc. depreciation, depletion and amortization for fiscal 2025 was $5.49M, a 14.32% increase from fiscal 2024.
- Omada Health, Inc. depreciation, depletion and amortization for fiscal 2024 was $4.80M, a 7.98% increase from fiscal 2023.
- Omada Health, Inc. depreciation, depletion and amortization for fiscal 2023 was $4.45M.
| Period end | Depreciation, Depletion and Amortization 3 month | Depreciation, Depletion and Amortization 6 month | Depreciation, Depletion and Amortization 9 month | Depreciation, Depletion and Amortization 12 month |
|---|---|---|---|---|
| 2026-06-30 | $1.58M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-07 | $3.09M 10-Q · filed 2026-08-07 | $4.54M derived: sum of 3 quarters · filed 2026-08-07 | $5.89M derived: sum of 4 quarters · filed 2026-08-07 |
| 2026-03-31 | $1.51M 10-Q · filed 2026-05-08 | $2.96M derived: sum of 2 quarters · filed 2026-05-08 | $4.31M derived: sum of 3 quarters · filed 2026-05-08 | $5.67M derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-12-31 | $1.45M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-06 | $2.81M derived: sum of 2 quarters · filed 2026-03-06 | $4.16M derived: sum of 3 quarters · filed 2026-08-07 | $5.49M 10-K · filed 2026-03-06 |
| 2025-09-30 | $1.36M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | $2.71M derived: sum of 2 quarters · filed 2026-08-07 | $4.04M 10-Q · filed 2025-11-07 | $5.32M derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-06-30 | $1.35M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-07 | $2.69M 10-Q · filed 2026-08-07 | $3.96M derived: sum of 3 quarters · filed 2026-08-07 | $5.19M derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-03-31 | $1.33M 10-Q · filed 2026-05-08 | $2.61M derived: sum of 2 quarters · filed 2026-05-08 | $3.84M derived: sum of 3 quarters · filed 2026-05-08 | |
| 2024-12-31 | $1.28M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-06 | $2.51M derived: sum of 2 quarters · filed 2026-03-06 | $4.80M 10-K · filed 2026-03-06 | |
| 2024-09-30 | $1.23M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | $3.52M 10-Q · filed 2025-11-07 | ||
| 2024-06-30 | $2.30M 10-Q · filed 2025-08-08 | |||
| 2023-12-31 | $4.45M 10-K · filed 2026-03-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| InnovAge Holding Corp. (INNV) | United States | $1.206B | -635.60 |
| U S PHYSICAL THERAPY INC /NV (USPH) | United States | $1.251B | 32.48 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| Strata Critical Medical, Inc. (SRTA) | United States | $0.467B | 11.33 |
| DocGo Inc. (DCGO) | United States | $0.034B | -0.25 |
| VSEE HEALTH, INC. (VSEE) | United States | $0.003B | |
| Agape ATP Corp (ATPC) | $0.002B | ||
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| GeneDx Holdings Corp. (WGS) | United States | $2.638B | -19.23 |
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |